{"id":"W2130952724","doi":"10.1093/eurheartj/ehm575","title":"New oral anticoagulants in atrial fibrillation","year":2007,"lang":"en","type":"review","venue":"European Heart Journal","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hamilton General Hospital","funders":"","keywords":"Medicine; Apixaban; Rivaroxaban; Dabigatran; Edoxaban; Stroke (engine); Atrial fibrillation; Warfarin; Direct thrombin inhibitor; Discovery and development of direct thrombin inhibitors; Antithrombotic; Intensive care medicine; Internal medicine; Thrombin; Platelet","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009016826,0.00105788,0.00184192,0.003706608,0.0003679442,0.0009301761,0.0008653566,0.001429404,0.00697675],"category_scores_gemma":[0.001280529,0.0003138887,0.0006798325,0.004179229,0.0005167683,0.001643169,0.0006655707,0.001766194,0.004489704],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005865912,"about_ca_system_score_gemma":0.001226558,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001509714,"about_ca_topic_score_gemma":0.002598089,"domain_scores_codex":[0.9994909,0.00009793272,0.00007903742,0.00006313877,0.0002396483,0.00002949241],"domain_scores_gemma":[0.9994498,0.0002357221,0.0000978372,0.00002128698,0.0001519593,0.000043442],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005941839,0.00009130692,0.0001891559,0.01486729,0.0001035558,0.0002701921,0.0000591499,0.0001632373,0.0007639524,0.001549846,0.0348843,0.9469985],"study_design_scores_gemma":[0.00005893064,0.0001077027,0.001165344,0.005879109,0.0001709125,0.002894195,0.00005972238,0.00005796607,0.0002457392,0.001673887,0.987671,0.00001549225],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006975178,0.9984054,0.00005961215,0.0001503787,0.0001783993,0.000006681546,0.000007785705,0.000005165843,0.001116791],"genre_scores_gemma":[0.0005247517,0.9980115,0.0002052688,0.0002049093,0.0002207611,0.000008700796,0.00002439738,0.000001094502,0.000798564],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00697675,"threshold_uncertainty_score":0.02333957,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3264621681291325,"score_gpt":0.4645953747228908,"score_spread":0.1381332065937583,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}